Log In
BCIQ
Print this Print this
 

LP-09

  Manage Alerts
Collapse Summary General Information
Company Lipella Pharmaceuticals Inc.
DescriptionLiposomal Botulinum toxin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today